New research finds pharmacist prescribing significantly reduces hypertensionEvidence from RxACTION study shows it is time to move from research to implementation, says Ross Tsuyuki. Trial trumpets LDL lowering Does sitagliptin increase cardiovascular risk in diabetes patients? New study shows no apparent increased risk of major adverse cardiovascular events or hospitalization for heart failure. Inaugural Peter Munk Chair in structural heart disease intervention announced Device treats heart failure via the spinal cord Technique has produced mixed results in trials Manitoba Health says pediatric cardiac care program not likely to be revived New simplified lipid pathway for reducing cardiovascular risk in primary care Alberta TOP clinical practice guideline streamlines statin prescribing and reduces lipid monitoring. Case Report: Dealing with dyslipidemia through positive dietary change Migraine is a cardiovascular risk factor Meta-analysis links the headaches with MI and angina 2015 Canadian hypertension guidelines Treatment targets and drug therapy recommendations remain unchanged from 2014. First Previous 42 43 44 45 46 Next Last
